
NOVEL MUTATIONS AND HAPLOTYPE ANALYSIS
OF GENOMIC POLYMORPHISMS OF GJB2 AND
GJB3 GENES ASSOCIATED WITH PROFOUND AND
MODERATELY SEVERE HEARING LOSS IN
PATIENTS FROM BASHKORTOSTAN
Dzhemileva LU*, Khidiyatova IM, Khabibullin RM, Khusnutdinova EK *Corresponding Author: Dr. Lilya U. Dzhemileva, Institute of Biochemistry and Genetics, Russian Academy of Sciences, Prospect Octyabrya 69, 450054, Ufa, Russia; Tel: +07-3472-355255; Fax: +07-3472-356100; E-mail: Dzhemilev@anrb.ru page: 41
|
Abstract
Congenital deafness is a relatively common human disorder, occurring, on average, in 1/1,000 newborns. This kind of disability hampers speech acquisition and, therefore, normal communication and social integration. Mutations in the GJB2 gene are responsible for more than a half of all cases of pre-lingual non-syndromic recessive and dominant deafness in many Caucasian populations. Apart from mutations in the GJB2 gene, the GJB3 gene mutations are also associated with inherited hearing loss, but the patients with GJB3 gene mutations have progressive age at onset, ranging from mild-moderate to profound hearing loss.
We have analyzed a total of 58 families (unrelated patients) with recessive or sporadic deafness from Bashkortostan (Russia) and 35 (60%) of them were found to carry the 35delG mutation. Five different GJB2 gene mutations, including three novel mutations, and one novel GJB3 gene mutation were identified.
In order to explore the ancestry of GJB2 mutations in the patients with non-syndromic inherited deafness, we estimated linkage disequilibrium between the 35delG mutation, other GJB2 gene mutations and flanking microsatellite markers D13S143, D13S292, and D13S175. Haplotype analysis of the markers D13S292, D13S175 and D13S143 in the peri-centromeric region of chromosome 13 helped to optimize DNA diagnostics of non-syndromic deafness in patients from Bashkortostan. The results presented here, can be used for the development of a simple molecular test, which will be of considerable help.
Key words: deafness; haplotype analysis; GJB2 and GJB3 genes; 35delG mutation; polymorphic loci.
|
|
|
|



 |
Number 27 VOL. 27 (2), 2024 |
Number 27 VOL. 27 (1), 2024 |
Number 26 Number 26 VOL. 26(2), 2023 All in one |
Number 26 VOL. 26(2), 2023 |
Number 26 VOL. 26, 2023 Supplement |
Number 26 VOL. 26(1), 2023 |
Number 25 VOL. 25(2), 2022 |
Number 25 VOL. 25 (1), 2022 |
Number 24 VOL. 24(2), 2021 |
Number 24 VOL. 24(1), 2021 |
Number 23 VOL. 23(2), 2020 |
Number 22 VOL. 22(2), 2019 |
Number 22 VOL. 22(1), 2019 |
Number 22 VOL. 22, 2019 Supplement |
Number 21 VOL. 21(2), 2018 |
Number 21 VOL. 21 (1), 2018 |
Number 21 VOL. 21, 2018 Supplement |
Number 20 VOL. 20 (2), 2017 |
Number 20 VOL. 20 (1), 2017 |
Number 19 VOL. 19 (2), 2016 |
Number 19 VOL. 19 (1), 2016 |
Number 18 VOL. 18 (2), 2015 |
Number 18 VOL. 18 (1), 2015 |
Number 17 VOL. 17 (2), 2014 |
Number 17 VOL. 17 (1), 2014 |
Number 16 VOL. 16 (2), 2013 |
Number 16 VOL. 16 (1), 2013 |
Number 15 VOL. 15 (2), 2012 |
Number 15 VOL. 15, 2012 Supplement |
Number 15 Vol. 15 (1), 2012 |
Number 14 14 - Vol. 14 (2), 2011 |
Number 14 The 9th Balkan Congress of Medical Genetics |
Number 14 14 - Vol. 14 (1), 2011 |
Number 13 Vol. 13 (2), 2010 |
Number 13 Vol.13 (1), 2010 |
Number 12 Vol.12 (2), 2009 |
Number 12 Vol.12 (1), 2009 |
Number 11 Vol.11 (2),2008 |
Number 11 Vol.11 (1),2008 |
Number 10 Vol.10 (2), 2007 |
Number 10 10 (1),2007 |
Number 9 1&2, 2006 |
Number 9 3&4, 2006 |
Number 8 1&2, 2005 |
Number 8 3&4, 2004 |
Number 7 1&2, 2004 |
Number 6 3&4, 2003 |
Number 6 1&2, 2003 |
Number 5 3&4, 2002 |
Number 5 1&2, 2002 |
Number 4 Vol.3 (4), 2000 |
Number 4 Vol.2 (4), 1999 |
Number 4 Vol.1 (4), 1998 |
Number 4 3&4, 2001 |
Number 4 1&2, 2001 |
Number 3 Vol.3 (3), 2000 |
Number 3 Vol.2 (3), 1999 |
Number 3 Vol.1 (3), 1998 |
Number 2 Vol.3(2), 2000 |
Number 2 Vol.1 (2), 1998 |
Number 2 Vol.2 (2), 1999 |
Number 1 Vol.3 (1), 2000 |
Number 1 Vol.2 (1), 1999 |
Number 1 Vol.1 (1), 1998 |
|
|